2018-10-31 14:42 阅读:1149次
题 目：The role of lncRNA H19 in cholestatic liver injury(广东药科大学海外名师项目)
主讲人：Huiping Zhou 博士
时 间：2018年11月2日（周五） 下午2:30-4:00
Dr. Huiping Zhou is a tenured Full Professor at the Department of Microbiology and Immunology, Virginia Commonwealth University and Research Career Scientist of McGuire VA Medical Center of Richmond. Dr. Zhou received her BS and MS from China Pharmaceutical University and Ph.D. from College of Pharmacy, University of Kentucky. Dr. Zhou’s research interest focuses on the study of ER stress, inflammation, bile acids and sphingosine 1-phosphate signaling in liver diseases including non-alcoholic fatty liver disease, alcoholic liver diseases, drug-induced liver injury and biliary diseases. She is a fellow of AGA and member of AASLD, ASBMB, ASIP, APS, APET and CALS. She serves as Basic Science Research Committee of AASLD and steering committee of cholestatic liver disease interest group of AASLD, APS Award Committee, AASLD foundation research award committee. She has been continuously funded by NIH, Veteran Merit Review Award and other funding agencies since 2005. She is currently serving as a member of The Study Section of Gastroenterology, VA Merit Review and ad hoc reviewer for several NIH study sections and an Overseas Member for National Science Foundation of China. She serves as an editorial board member for Hepatology, World Journal of Gastroenterology, Liver Research and Digestive Liver Disease. She reviewed manuscripts for more than 60 different journals. She has published more than 160 peer-reviewed papers and review articles in top journals including Hepatology, Gastroenterology, JBC, Molecular Pharmacology, and AJP-GI. She has trained more than 40 graduate students and post-doctoral fellows. She received 2018 WISDM (Women in Science, Dentistry & Medicine) Professional Achievement Award from School of Medicine, Virginia Commonwealth University and Research Career Scientist Award from Department of Veterans Affairs.